1999
DOI: 10.1002/(sici)1098-2744(199905)25:1<21::aid-mc3>3.0.co;2-s
|View full text |Cite
|
Sign up to set email alerts
|

Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible wistar rat strain

Abstract: Persistent liver nodules (PNs) and hepatocellular carcinomas (HCCs) induced in F344 rats by the resistant hepatocyte (RH) model exhibit c-myc overexpression and amplification. The role of these changes in progression of PN was investigated in nodules with different propensities to evolve to HCC in resistant Wistar rats and, for comparison, in susceptible F344 rats. Initiation of rats with diethylnitrosamine was followed by selection with 2-acetylaminofluorene (AAF) plus partial hepatectomy (RH groups). Two add… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2000
2000
2017
2017

Publication Types

Select...
7
1

Relationship

5
3

Authors

Journals

citations
Cited by 34 publications
(21 citation statements)
references
References 32 publications
0
21
0
Order By: Relevance
“…c-myc and c-myc target genes, including Cyclin E, E2F1 and Odc, 36 are upregulated in neoplastic liver lesions of rodents and humans, and this is influenced by genetic predisposition to hepatocarcinogenesis. 24,27,37 Genes involved in cell growth regulation located at the Hcrem2 locus include Adra2a and Adrb1, encoding adrenergic receptors ␣2a and ␤1, respectively, and Prkg1 and Cyp17, which are deregulated in rat and/or human HCC. 38,39 Cyp17 encodes cytochrome P-450-17␣, which mediates 17␣-hydroxylase and 17,20-lyase activities in the androgen biosynthesis pathway.…”
Section: Epistatic Locimentioning
confidence: 99%
See 1 more Smart Citation
“…c-myc and c-myc target genes, including Cyclin E, E2F1 and Odc, 36 are upregulated in neoplastic liver lesions of rodents and humans, and this is influenced by genetic predisposition to hepatocarcinogenesis. 24,27,37 Genes involved in cell growth regulation located at the Hcrem2 locus include Adra2a and Adrb1, encoding adrenergic receptors ␣2a and ␤1, respectively, and Prkg1 and Cyp17, which are deregulated in rat and/or human HCC. 38,39 Cyp17 encodes cytochrome P-450-17␣, which mediates 17␣-hydroxylase and 17,20-lyase activities in the androgen biosynthesis pathway.…”
Section: Epistatic Locimentioning
confidence: 99%
“…11,22,24 -26 The growth rate of neoplastic hepatocytes is under the control of Hcs and Hcr loci. 24,27 However, the genes and molecular mechanisms responsible for remodeling are unknown. Mapping of the genes regulating remodeling may contribute to our understanding of the mechanisms of neoplastic lesion regression and the genetically transmitted resistance to hepatocarcinogenesis.…”
mentioning
confidence: 99%
“…Reverse transcription-polymerase chain reaction (RT-PCR) was performed by a modification of the comparative PCR method. 38,39 In brief, master solutions, containing 0.8 µg/µL of total RNA from different tissues, were diluted 1:2, 1:4, and 1:8 (vulval). The reaction mixture was made up by adding 43 µL of water to Eppendorf tubes containing predispersed Ready-to-Go beads (Amersham Pharmacia Biotech, Piscataway, NJ); 5-µL aliquots of each mRNA dilution were added to a series of 3 tubes per each tissue, followed up by the appropriate primers (1 µL each; Table 1).…”
Section: Animals and Treatmentmentioning
confidence: 99%
“…However, the expression of this gene is much higher in preneoplastic and neoplastic lesions of F344 rats than in the lesions of BN rats [56,58,59] . c-Myc is frequently amplified in preneoplastic and neoplastic lesions of the susceptible strain, but not in the lesions of the resistant BN and Wistar strains [60] . Taken together, these observations suggest the existence of some connections between c-Myc and the susceptibility genes that regulate redifferentiation.…”
Section: Cell Cycle Deregulationmentioning
confidence: 97%